Exelixis (EXEL)

Add to Watchlists
Create an Alert
5.73 +0.19  +3.43% NASDAQ Jul 31, 20:00 Delayed 2m USD
View Full Chart
EXEL Price Chart
View All Events

EXEL Events

Date Type Description
08/11/2015 17:00 EDT Misc Exelixis Inc Second Quarter Earnings Conference Call in 2015
08/11/2015 Earnings Exelixis Inc Second Quarter Earnings in 2015 Release
04/30/2015 17:00 EDT Misc Exelixis Inc First Quarter Earnings Conference Call in 2015
04/30/2015 Earnings Exelixis Inc First Quarter Earnings in 2015 Release
02/24/2015 17:00 EST Misc Exelixis Inc Fourth Quarter Earnings Conference Call in 2014
02/24/2015 Earnings Exelixis Inc Fourth Quarter Earnings in 2014 Release
02/11/2015 11:30 EST Misc Exelixis to Present at the Leerink Global Healthcare Conference
11/04/2014 14:00 PDT Misc Q3 2014 Exelixis, Inc. Financial Results Conference Call
11/04/2014 Earnings Exelixis, Inc. Q3 2014 Financial Results
View All Performance Charts

EXEL Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Exelixis is up 42.18% over the last year vs S&P 500 Total Return up 11.21%, Roche Holding up 2.42%, and Immunogen up 67.16%.

PDF Report for EXEL

Download EXEL Pro Report PDF
Advertisement

EXEL Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.exelixis.com
  • IR Website: http://www.exelixis.com/investors-media
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: Aug. 11, 2015
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Sector: Professional, Scientific, and Technical Services

Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.

EXEL Excel Add-In Codes

  • Name: =YCI("EXEL","name")
  • Description: =YCI("EXEL","description")
  • Sector: =YCI("EXEL","sector")
  • Industry: =YCI("EXEL","industry")
  • Est. Current Fiscal Year End: =YCI("EXEL","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.